Pfizer Global Pharmaceuticals

Pfizer's contribution to therapeutic medicines in Australia dates back to 1886, and goes well beyond the realm of its ophthalmology portfolio.

Pfizer's dedication to ongoing research and development has led to the introduction of many leading prescription medicines in a diverse range of therapeutic areas such as cardiovascular, neuroscience and musculo-skeletal medicine.

Pfizer has also has a long-standing commitment to many global philanthropic programs - none more significant than the International Trachoma Initiative, with the aim of this project being to eradicate the world's most preventable form of blindness by the year 2020.